Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study

por Dickinson, L, Amin, J, Else, L, Boffito, M, Egan, D, Owen, A, Khoo, S, Back, D, Orrell, C, Clarke, A, Losso, M, Phanuphak, P, Carey, D, Cooper, DA, Emery, S
Publicado 2015

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study...

por Nash, S., Dietrich, J., Ssemata, A. S., Herrera, C., O’Hagan, K., Else, L., Chiodi, F., Kelly, C., Shattock, R., Chirenje, M., Lebina, L., Khoo, S., Bekker, L-G, Weiss, H. A., Gray, C., Stranix-Chibanda, L., Kaleebu, P., Seeley, J., Martinson, N., Fox, J.
Publicado 2020